188 afleveringen

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

pharmaphorum Podcast pharmaphorum

    • Wetenschap

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

    Move over CAR-T: The potential of NK cells in cell therapy

    Move over CAR-T: The potential of NK cells in cell therapy

    On today’s podcast, Dr. Fred Aslan, CEO of Artiva Biosciences, joins host Jonah Comstock to talk more about this newer avenue in cell therapy. They discuss the potential of NK cells to provide effective allogeneic cell therapy, the potential of the therapy in auto-immune disease, and the importance of a robust manufacturing process that can get a high number of doses from a small amount of donated tissue.

    • 34 min.
    Working for a mature form of genomic medicines

    Working for a mature form of genomic medicines

    In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.

    • 20 min.
    Challenges and opportunities in synthetic clinical trials

    Challenges and opportunities in synthetic clinical trials

    On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, talk about this trend, where the industry is now, and what they’re doing to move it along.

    • 44 min.
    The commercialisation of quantum science in pharma

    The commercialisation of quantum science in pharma

    In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.

    • 26 min.
    Conference report: Reuters Pharma Europe

    Conference report: Reuters Pharma Europe

    In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona. 

    • 37 min.
    In vitro gametogenesis: the science has to be right, and it has to be safe

    In vitro gametogenesis: the science has to be right, and it has to be safe

    Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).

    • 16 min.

Top-podcasts in Wetenschap

NRC Onbehaarde Apen
NRC
De Universiteit van Nederland Podcast
Universiteit van Nederland
Ondertussen in de kosmos
de Volkskrant
Pandapunten
WWF
Zimmerman en Space
Hens Zimmerman
We zijn toch niet gek?
Suzanne Rethans

Suggesties voor jou

The Readout Loud
STAT
Tradeoffs
Tradeoffs
Up First
NPR
The Daily
The New York Times
The Rest Is Politics
Goalhanger Podcasts
Global Medical Device Podcast powered by Greenlight Guru
Greenlight Guru + Medical Device Entrepreneurs